Side Effects

Does GLP-1 Cause Pancreatitis? What You Need to Know

If you're considering or already taking a GLP-1 medication like semaglutide or tirzepatide, you've probably heard concerns about pancreatitis. Maybe you've seen warnings online or had a worried friend share an article. It's natural to want answers when it comes to your health.

Here's the honest truth: while pancreatitis has been reported in people taking GLP-1 medications, the actual risk appears to be very small. More importantly, many people who develop pancreatitis while on these medications have other risk factors that likely played a larger role. Let's break down what we actually know.

What Is Pancreatitis?

Pancreatitis is inflammation of the pancreas, the organ that produces digestive enzymes and insulin. It can be acute (sudden and severe) or chronic (long-lasting).

Symptoms typically include severe upper abdominal pain that may radiate to your back, nausea, vomiting, and tenderness when touching your abdomen. Acute pancreatitis is a serious condition that requires immediate medical attention.

The most common causes of pancreatitis include gallstones, heavy alcohol use, certain medications, high triglyceride levels, and obesity—many of which overlap with conditions that lead people to seek GLP-1 therapy in the first place.

What Does the Research Show?

The relationship between GLP-1 medications and pancreatitis has been studied extensively, and the findings are reassuring overall.

Clinical Trial Data

In large clinical trials for semaglutide and tirzepatide, cases of pancreatitis were rare in both the medication and placebo groups. The rates were similar enough that researchers couldn't definitively link the medications to increased risk.

For example, in the SUSTAIN trials for semaglutide, pancreatitis occurred in less than 0.2% of participants. In the SURPASS trials for tirzepatide, rates were similarly low.

Real-World Studies

Multiple large population studies have looked at people taking GLP-1 medications in everyday settings, not just controlled trials. Most of these studies found no increased risk of pancreatitis compared to people taking other diabetes medications.

A 2017 study published in JAMA Internal Medicine analyzed data from over 1.3 million patients and found no association between GLP-1 use and hospitalization for pancreatitis.

Understanding Your Personal Risk Factors

What matters more than the medication itself are the risk factors you bring to the table.

People with obesity and type 2 diabetes—the primary users of GLP-1 medications—already have a higher baseline risk of pancreatitis compared to the general population. This makes it challenging to separate the medication's effects from underlying health conditions.

Known Risk Factors for Pancreatitis

If you have several of these risk factors, it's especially important to discuss them with your healthcare provider before starting GLP-1 therapy.

Gender Differences in Pancreatitis Risk

While both men and women can develop pancreatitis, there are some gender-specific considerations worth noting.

Women are more likely to develop gallstone-related pancreatitis, particularly during childbearing years and with rapid weight loss. Since GLP-1 medications promote weight loss, women should be especially attentive to symptoms of gallbladder issues, including pain in the upper right abdomen after eating fatty foods.

Men, on the other hand, are more likely to develop alcohol-related pancreatitis. If you're male and taking a GLP-1 medication, limiting alcohol consumption becomes even more important for protecting your pancreatic health.

Warning Signs to Watch For

Regardless of the low statistical risk, it's important to know what symptoms require immediate medical attention.

Seek emergency care if you experience severe, persistent abdominal pain, especially if it's accompanied by nausea, vomiting, fever, or rapid heartbeat. This is particularly important if the pain is intense and doesn't improve with position changes or over-the-counter medications.

Most people on GLP-1 medications experience mild, temporary digestive symptoms like nausea or stomach discomfort as their body adjusts. These are different from pancreatitis pain, which is typically severe and unrelenting.

What Your Healthcare Provider Should Know

Before starting any GLP-1 medication, have an honest conversation with your provider about your complete medical history.

Mention any previous episodes of pancreatitis, gallbladder problems, or family history of pancreatic issues. Your provider may want to check your triglyceride levels and assess your overall risk profile.

If you've had pancreatitis in the past, GLP-1 medications aren't automatically off the table, but they require more careful consideration and monitoring.

The Bottom Line on GLP-1 and Pancreatitis

The available evidence suggests that GLP-1 medications do not significantly increase the risk of pancreatitis for most people. The benefits of these medications for weight loss and metabolic health typically outweigh the small potential risk.

That said, everyone's health situation is unique. Your personal risk factors matter more than population-level statistics. Working with a knowledgeable healthcare provider who understands both GLP-1 therapy and your individual health profile is essential.

If you're already taking a GLP-1 medication and feeling well, there's no reason to worry excessively about pancreatitis. Simply stay aware of the warning signs and maintain open communication with your healthcare team.

From the Ozari Care Team

If you have a history of elevated triglycerides, ask your provider to recheck your levels a few months after starting GLP-1 therapy. The weight loss these medications promote often helps lower triglycerides, which may actually reduce your pancreatitis risk over time. Stay hydrated and contact us immediately if you develop severe abdominal pain.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically Reviewed — Ozari Clinical Content Team (OCCT). Health writers and wellness professionals specializing in GLP-1 therapy, metabolic health, and weight loss medicine. Content reviewed in accordance with Ozari's Editorial Standards. Last reviewed: April 25, 2026.

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

Last reviewed: April 25, 2026